Title
|
|
|
|
Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
It is currently estimated that about 0.5% of patients will develop Kaposi's sarcoma (KS) after kidney transplantation. Tapering of immunosuppression often leads to KS remission, but also results in graft loss in more than 50% of cases. Whether retransplantation is safe in these patients is unknown. We here report on eight patients who developed KS recurrence after kidney transplantation-(A) Patients with previously treated KS: There were 4 patients who had clinical remission of KS (including three posttransplantation) for periods ranging from 5 months up to 19 years before transplantation. All 4 developed KS recurrence within months after transplantation. In 3 patients, KS regressed only when all immunosuppression was discontinued, at the price of allograft removal. Partial remission occurred in the fourth patient following reduction of immunosuppression and gancyclovir administration; (B) Patients with recurrent KS during a single transplant: 4 patients developed KS after transplantation that regressed following reduction of immunosuppressive therapy. Increased immunosuppression, in the form of steroid pulses in 3 patients was associated with recurrence of KS. Subsequent reduction of immunosuppression caused regression of KS in all 4 patients, but 2 recipients lost their allografts. These data emphasize the high risk of recurrence of KS after renal transplantation. If physicians decide to transplant patients with a history of KS, they should inform the future recipient of the possibility of KS recurrence. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Transplantation. - Baltimore, Md, 1963, currens
| |
Publication
|
|
|
|
Baltimore, Md
:
1996
| |
ISSN
|
|
|
|
0041-1337
1534-6080
[online]
| |
DOI
|
|
|
|
10.1097/00007890-199608270-00007
| |
Volume/pages
|
|
|
|
62
:4
(1996)
, p. 463-466
| |
ISI
|
|
|
|
A1996VE75100007
| |
Full text (Publisher's DOI)
|
|
|
|
| |
|